𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of a Human Small-cell Lung Cancer Cell Line Resistant to a New Water-soluble Camptothecin Derivative, DX-8951f

✍ Scribed by Nomoto, Taisuke ;Nishio, Kazuto ;Ishida, Tomoyuki ;Mori, Masatomo ;Saijo, Nagahiro


Book ID
108581536
Publisher
Wiley (Blackwell Publishing)
Year
1998
Tongue
English
Weight
386 KB
Volume
89
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


DX-8951F, a water-soluble camptothecin a
✍ Noriko Joto; Mineko Ishii; Megumi Minami; Hiroshi Kuga; Ikuo Mitsui; Akiko Tohgo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 190 KB

We previously reported that DX-8951f, a novel watersoluble camptothecin analog, significantly inhibits the growth of various human and murine tumors in vitro and in vivo. The antitumor effects and topoisomerase I inhibitory activity of DX-8951f are stronger than those of other current camptothecin a

Establishment of a human non-small cell
✍ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m